From enzymes and lipid nanoparticles to large-scale process design, four global innovators redefine RNA-based medicine development and delivery.

BIOVECTRA and Revolution Biomanufacturing partner to integrate mRNA sequence design with end-to-end GMP manufacturing for ...

Discover expert strategies for selecting optimal labels for single particle tracking in super-resolution microscopy ...

Estrella Immunopharma, Inc. ("Estrella" or the "Company"), a clinical stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS® T-cell therapies to treat cancer and autoimmune ...

Treatment with an intramuscular hepatocyte growth factor reduced healing time and promoted full ulcer healing compared with placebo in patients with peripheral artery disease.

Progression free survival (PFS) of 74% at 16 months compares favourably to standard of care PFS of 50% at 11.5 months 1 Strong PFS consistent across key subgroups Reaffirms selection of iSCIB1+ and ...

Today, NeuroVice announced that PATI is now commercially available, marking a breakthrough moment for millions of patients living with focal and grand-mal seizures. The company will debut the ...

At an apple processing facility in Watsonville, the 2025 UC Santa Cruz iGEM team took a deep dive into mycotoxins in food, ...

TriLink BioTechnologies senior scientist Dr Cody Palumbo discusses the blockers to manufacturing mRNA-based gene editing ...

Technologies needed for tracing engineered biothreats back to their sources are advancing rapidly. Here are some ...

Background Chronic stress is a known risk factor for cancer metastasis. However, the underlying mechanisms, particularly ...

Creative Biogene is always dedicated to providing researchers with the products and tools they deeply need to advance their research to new frontiers.